May 16, 2016
AbSci announced today the appointment of V. Bryan Lawlis, Ph.D. to AbSci’s Board of Directors. Dr. Lawlis has been the CEO and founder of numerous biotechnology companies and currently serves on the Board of Directors of BioMarin Pharmaceutical, Inc., Coherus...
May 16, 2016
AbSci, which manufactures soluble microbial proteins, said it secured $5.1 million in a round of Series A financing that it plans to use to speed up commercialization of its protein expression platform used in biopharmaceutical manufacturing. The fundraising was led...
Apr 11, 2016
Funding will accelerate commercialization of AbSci’s SoluProTM protein expression platform for use in biopharmaceutical manufacturing. Portland, Oregon, April 11, 2016: AbSci, a global leader in soluble microbial protein expression has secured $5.1M in Series A...